Guobang Pharma Ltd (605507) — Cash Flow Quality Index
Guobang Pharma Ltd (605507) has a Cash Flow Quality Index of 1.45x as of September 2025. Operating cash flow of CN¥311.27 Million exceeds net income of CN¥214.67 Million, indicating high earnings quality where cash backs reported profits. Explore 605507 cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Guobang Pharma Ltd Cash Flow Quality Index (2017–2025)
Historical Cash Flow Quality Index for Guobang Pharma Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Guobang Pharma Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Guobang Pharma Ltd (2017–2025)
Year-by-year earnings quality comparison for Guobang Pharma Ltd. For live market cap and the full company financial profile, see 605507 company net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.68x | CN¥559.28 Million | CN¥820.82 Million | ▼ -24.7% |
| 2024 | 0.90x | CN¥706.41 Million | CN¥780.58 Million | ▲ +7.3% |
| 2023 | 0.84x | CN¥516.76 Million | CN¥612.46 Million | ▼ -23.6% |
| 2022 | 1.10x | CN¥1.02 Billion | CN¥920.62 Million | ▲ +542.8% |
| 2021 | -0.25x | CN¥-176.18 Million | CN¥706.23 Million | ▼ -126.3% |
| 2020 | 0.95x | CN¥767.70 Million | CN¥810.29 Million | ▲ +6.2% |
| 2019 | 0.89x | CN¥440.86 Million | CN¥494.01 Million | ▼ -20.4% |
| 2018 | 1.12x | CN¥541.68 Million | CN¥483.46 Million | ▲ +196.1% |
| 2017 | 0.38x | CN¥148.03 Million | CN¥391.25 Million | — |